Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP623379.RA_XYF4l2N5S2zzwfUsXXR7oNNTp_gudZL8r0rmfVvUuw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP623379.RA_XYF4l2N5S2zzwfUsXXR7oNNTp_gudZL8r0rmfVvUuw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP623379.RA_XYF4l2N5S2zzwfUsXXR7oNNTp_gudZL8r0rmfVvUuw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP623379.RA_XYF4l2N5S2zzwfUsXXR7oNNTp_gudZL8r0rmfVvUuw130_provenance.
- NP623379.RA_XYF4l2N5S2zzwfUsXXR7oNNTp_gudZL8r0rmfVvUuw130_assertion description "[The EGR1 transactivator is overexpressed in prostate cancer, and its expression pattern suggests that EGR1 could potentially regulate a number of steps involved in initiation and progression of prostate cancer, such as mitogenesis, invasiveness, angiogenesis, and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP623379.RA_XYF4l2N5S2zzwfUsXXR7oNNTp_gudZL8r0rmfVvUuw130_provenance.
- NP623379.RA_XYF4l2N5S2zzwfUsXXR7oNNTp_gudZL8r0rmfVvUuw130_assertion evidence source_evidence_literature NP623379.RA_XYF4l2N5S2zzwfUsXXR7oNNTp_gudZL8r0rmfVvUuw130_provenance.
- NP623379.RA_XYF4l2N5S2zzwfUsXXR7oNNTp_gudZL8r0rmfVvUuw130_assertion SIO_000772 10984481 NP623379.RA_XYF4l2N5S2zzwfUsXXR7oNNTp_gudZL8r0rmfVvUuw130_provenance.
- NP623379.RA_XYF4l2N5S2zzwfUsXXR7oNNTp_gudZL8r0rmfVvUuw130_assertion wasDerivedFrom befree-20140225 NP623379.RA_XYF4l2N5S2zzwfUsXXR7oNNTp_gudZL8r0rmfVvUuw130_provenance.
- NP623379.RA_XYF4l2N5S2zzwfUsXXR7oNNTp_gudZL8r0rmfVvUuw130_assertion wasGeneratedBy ECO_0000203 NP623379.RA_XYF4l2N5S2zzwfUsXXR7oNNTp_gudZL8r0rmfVvUuw130_provenance.
- befree-20140225 importedOn "2014-02-25" NP623379.RA_XYF4l2N5S2zzwfUsXXR7oNNTp_gudZL8r0rmfVvUuw130_provenance.